These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Deprescribing antihypertensive drugs after starting OSA primary therapy: "first do no net harm?". Romigi A Sleep; 2022 Sep; 45(9):. PubMed ID: 35802048 [No Abstract] [Full Text] [Related]
3. Impact of OSA primary therapy on antihypertensive drugs use. Revol B; Castelli C; Joyeux-Faure M; Pépin JL Sleep; 2022 Sep; 45(9):. PubMed ID: 35802044 [No Abstract] [Full Text] [Related]
9. Antihypertensive treatment in people of very old age with frailty: time for a paradigm shift? Shantsila E; Lip GYH; Shantsila A; Kurpas D; Beevers G; Gill PS; Williams NH J Hypertens; 2023 Oct; 41(10):1502-1510. PubMed ID: 37432893 [TBL] [Abstract][Full Text] [Related]
10. Effect of a patient-centred deprescribing procedure in older multimorbid patients in Swiss primary care - A cluster-randomised clinical trial. Zechmann S; Senn O; Valeri F; Essig S; Merlo C; Rosemann T; Neuner-Jehle S BMC Geriatr; 2020 Nov; 20(1):471. PubMed ID: 33198634 [TBL] [Abstract][Full Text] [Related]
11. Deprescribing in Older Adults With Cancer and Limited Life Expectancy: An Integrative Review. Brokaar EJ; van den Bos F; Visser LE; Portielje JEA Am J Hosp Palliat Care; 2022 Jan; 39(1):86-100. PubMed ID: 33739162 [TBL] [Abstract][Full Text] [Related]
12. Deprescribing Antihypertensive Medications for Patients Aged 80 Years or Older: Is Doing Less Doing No Harm? Peterson ED; Rich MW JAMA; 2020 May; 323(20):2024-2026. PubMed ID: 32453349 [No Abstract] [Full Text] [Related]
13. GPs' mindlines on deprescribing antihypertensives in older patients with multimorbidity: a qualitative study in English general practice. Kuberska K; Scheibl F; Sinnott C; Sheppard JP; Lown M; Williams M; Payne RA; Mant J; McManus RJ; Burt J Br J Gen Pract; 2021 Jul; 71(708):e498-e507. PubMed ID: 34001537 [TBL] [Abstract][Full Text] [Related]
14. A systematic review of randomised-controlled trials on deprescribing outcomes in older adults with polypharmacy. Omuya H; Nickel C; Wilson P; Chewning B Int J Pharm Pract; 2023 Jun; 31(4):349-368. PubMed ID: 37155330 [TBL] [Abstract][Full Text] [Related]
15. Deprescribing in Advanced Illness: Aligning Patient, Clinician, and Health Plan Goals. Parekh N; Schenker Y; Good CB; Neilson L; Shrank WH J Gen Intern Med; 2019 Apr; 34(4):631-633. PubMed ID: 30719644 [TBL] [Abstract][Full Text] [Related]
16. Feasibility of a protocol for deprescribing antihypertensive medication in older patients in Dutch general practices. Hassan D; Versmissen J; Hek K; van Dijk L; van den Bemt PMLA BMC Prim Care; 2022 Nov; 23(1):280. PubMed ID: 36352363 [TBL] [Abstract][Full Text] [Related]
17. [Obstructive sleep apnea and drugs as causes of treatment-resistant hypertension]. Waeber B; Feihl F Rev Med Suisse; 2012 Jan; 8(323):28-30. PubMed ID: 22303736 [TBL] [Abstract][Full Text] [Related]
18. Targeted Deprescribing in an Outpatient Hemodialysis Unit: A Quality Improvement Study to Decrease Polypharmacy. McIntyre C; McQuillan R; Bell C; Battistella M Am J Kidney Dis; 2017 Nov; 70(5):611-618. PubMed ID: 28416321 [TBL] [Abstract][Full Text] [Related]
19. Risk of resistant hypertension associated with insomnia in patients with obstructive sleep apnea. Wu H; Guo Y Sleep Med; 2023 Jan; 101():445-451. PubMed ID: 36516601 [TBL] [Abstract][Full Text] [Related]
20. Association of severe obstructive sleep apnea and elevated blood pressure despite antihypertensive medication use. Walia HK; Li H; Rueschman M; Bhatt DL; Patel SR; Quan SF; Gottlieb DJ; Punjabi NM; Redline S; Mehra R J Clin Sleep Med; 2014 Aug; 10(8):835-43. PubMed ID: 25126027 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]